Regeneron Pharmaceuticals, Inc. (ETR:RGO)
Germany
· Delayed Price · Currency is EUR 618.40
-5.20 (-0.83%)
At close: Dec 5, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €63.36 billion as of December 5, 2025. Its market cap has decreased by -18.32% in one year.
Market Cap
63.36B
Enterprise Value
49.58B
Revenue
12.14B
Ranking
n/a
PE Ratio
16.24
Stock Price
€618.40
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 63.36B, an increase of 48,111.72%. That is a compound annual growth rate of 20.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 181.89B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |